73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Phase I clinical trial of the first drug to successfully inhibit the MYC gene that drives many common cancers

Phase I clinical trial of the first drug to successfully inhibit the MYC gene that drives many common cancers

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainResearchers report that a drug targeting the cancer-causing gene MYC inhibits the function of the gene in

Phase I clinical trial of the first drug to successfully inhibit the MYC gene that drives many common cancers

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainResearchers report that a drug targeting the cancer-causing gene MYC inhibits the function of the gene in
Cancer screening and detection remain below prepandemic levels

Cancer screening and detection remain below prepandemic levels

At the end of 2021, population-based screening and diagnosis remained below prepandemic levels for breast, cervical, and colorectal cancers, according to a research letter published online Nov. 17 in&

Cancer screening and detection remain below prepandemic levels

At the end of 2021, population-based screening and diagnosis remained below prepandemic levels for breast, cervical, and colorectal cancers, according to a research letter published online Nov. 17 in&
How cellular plasticity drives cancer metastasis

How cellular plasticity drives cancer metastasis

by Ian Demsky,Memorial Sloan Kettering Cancer CenterCredit: Unsplash/CC0 Public DomainAbout 90% of deaths from cancer are a result of metastasis—that is, from cancer's ability to spread from

How cellular plasticity drives cancer metastasis

by Ian Demsky,Memorial Sloan Kettering Cancer CenterCredit: Unsplash/CC0 Public DomainAbout 90% of deaths from cancer are a result of metastasis—that is, from cancer's ability to spread from
Standard pathology tests outperform molecular subtyping in bladder cancer

Standard pathology tests outperform molecular subtyping in bladder cancer

byMedical College of Georgia at Augusta UniversityDr. Vinata B. Lokeshwar and graduate students Sarrah S. Lahorewala and Daley S. Morera. Credit: Phil Jones, Senior Photographer, Augusta Univers

Standard pathology tests outperform molecular subtyping in bladder cancer

byMedical College of Georgia at Augusta UniversityDr. Vinata B. Lokeshwar and graduate students Sarrah S. Lahorewala and Daley S. Morera. Credit: Phil Jones, Senior Photographer, Augusta Univers
Colonoscopy is the most comprehensive screening for colorectal cancer, despite flawed interpretations of a new study

Colonoscopy is the most comprehensive screening for colorectal cancer, despite flawed interpretations of a new study

by Franklin G. Berger,The ConversationCredit: American College of GastroenterologyA recently published study in a high-profile medical journal appeared to call into questionthe efficacy of

Colonoscopy is the most comprehensive screening for colorectal cancer, despite flawed interpretations of a new study

by Franklin G. Berger,The ConversationCredit: American College of GastroenterologyA recently published study in a high-profile medical journal appeared to call into questionthe efficacy of
Early clinical trial data show gene therapy reversing sickle cell anemia

Early clinical trial data show gene therapy reversing sickle cell anemia

by Cincinnati Children's Hospital Medical CenterTechnicians work in the ISO-certified cleanroom laboratory at Cincinnati Children's, where gene-correction therapies are tested and produce

Early clinical trial data show gene therapy reversing sickle cell anemia

by Cincinnati Children's Hospital Medical CenterTechnicians work in the ISO-certified cleanroom laboratory at Cincinnati Children's, where gene-correction therapies are tested and produce
Protein transformation drives cancer development

Protein transformation drives cancer development

byNorthwestern UniversityMitochondria. Credit: Wikipedia commonsA change in function in a mitochondrial antioxidant protein increases stem cell gene expression that promotes the development of m

Protein transformation drives cancer development

byNorthwestern UniversityMitochondria. Credit: Wikipedia commonsA change in function in a mitochondrial antioxidant protein increases stem cell gene expression that promotes the development of m
Finding a non-invasive way to predict effectiveness of cancer therapy

Finding a non-invasive way to predict effectiveness of cancer therapy

by Society of Nuclear Medicine and Molecular ImagingBiodistribution of 89Zr-labeled mAb: physiologic components. (A) Reversible nonspecific uptake due to antibody in vascular tissue compartment and an

Finding a non-invasive way to predict effectiveness of cancer therapy

by Society of Nuclear Medicine and Molecular ImagingBiodistribution of 89Zr-labeled mAb: physiologic components. (A) Reversible nonspecific uptake due to antibody in vascular tissue compartment and an
Patients with high-risk melanoma had better quality of life on pembrolizumab than on standard immunotherapy regimens

Patients with high-risk melanoma had better quality of life on pembrolizumab than on standard immunotherapy regimens

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainPatients with high-risk stage III-IV melanoma who received pembrolizumab after their surgery reported a better quality of life than pati

Patients with high-risk melanoma had better quality of life on pembrolizumab than on standard immunotherapy regimens

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainPatients with high-risk stage III-IV melanoma who received pembrolizumab after their surgery reported a better quality of life than pati
FDA approves Abecma for relapsed, refractory multiple myeloma

FDA approves Abecma for relapsed, refractory multiple myeloma

by Lori SolomonThe U.S. Food and Drug Administration has approved Abecma (idecabtagene vicleucel) as a personalized CAR T-cell therapy for triple-class exposed relapsed or refractory multiple myeloma.

FDA approves Abecma for relapsed, refractory multiple myeloma

by Lori SolomonThe U.S. Food and Drug Administration has approved Abecma (idecabtagene vicleucel) as a personalized CAR T-cell therapy for triple-class exposed relapsed or refractory multiple myeloma.
Integrating mental health services into oncology treatment protocols

Integrating mental health services into oncology treatment protocols

byThe City University of New YorkStudy participant is interviewed. Credit: The City University of New YorkA new study by CUNY SPH doctoral student Thinh Vu and colleagues reveals that cancer inp

Integrating mental health services into oncology treatment protocols

byThe City University of New YorkStudy participant is interviewed. Credit: The City University of New YorkA new study by CUNY SPH doctoral student Thinh Vu and colleagues reveals that cancer inp
Prostate cancer can now be diagnosed better using artificial intelligence

Prostate cancer can now be diagnosed better using artificial intelligence

byRadboud UniversityMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Researchers at Radboud university medical cen

Prostate cancer can now be diagnosed better using artificial intelligence

byRadboud UniversityMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Researchers at Radboud university medical cen